Discovery of new acetylcholinesterase and butyrylcholinesterase inhibitors through structure-based virtual screening
Yao Chen(Nanjing University of Chinese Medicine), Haopeng Sun(China Pharmaceutical University), Wei Li(Nanjing University of Chinese Medicine), Yaoyao Bian(Nanjing University of Chinese Medicine), Liang Wu(Nanjing University of Chinese Medicine), Hongyu Yang(China Pharmaceutical University), Renxiang Tan(Nanjing University of Chinese Medicine), Yuqiong Pei(Nanjing University of Chinese Medicine), Hongzhi Lin(China Pharmaceutical University), Tingming Fu(Nanjing University of Chinese Medicine)
Cited by 67
Related Papers
Degradation of proteins by PROTACs and other strategies
|Acta Pharmaceutica Sinica B|2019|312
Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease
|European Journal of Medicinal Chemistry|2017|307
Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms
|Journal of Medicinal Chemistry|2019|270
Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease
|European Journal of Medicinal Chemistry|2018|200
Strategies for Structural Modification of Small Molecules to Improve Blood–Brain Barrier Penetration: A Recent Perspective
|Journal of Medicinal Chemistry|2021|196